-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – vonoprazan fumarate
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry vonoprazan fumarate Drug Details Vonoprazan fumarate (Takecab, Inzelm, Vocinti, Denziza) is a novel anti-secretory...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – tegoprazan
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry tegoprazan Drug Details Tegoprazan (RQ-00000004, CJ-12420) is a benzimidazole derivative acts as antiulcer agent....
-
Product Insights
Nonerosive Reflux Disease (NERD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Nonerosive Reflux Disease (NERD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Nonerosive Reflux Disease (NERD) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Nonerosive Reflux Disease (NERD), complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history...
-
Product Insights
Reflux Esophagitis (Gastroesophageal Reflux Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Gastroesophageal reflux disease (GERD) is when the liquid content of the stomach refluxes into the esophagus, that condition. It is a chronic condition. The symptoms of GERD are nausea, heartburn and vomiting. The predisposing factors include eating large meals, which can cause the Lower Esophageal Sphincter (LES) to open inappropriately, as well as obesity, pregnancy, greasy food and certain drugs. The GERD research report provides a comprehensive overview on the therapeutics under development for GERD, complete with analysis by stage...
-
Product Insights
Nonerosive Reflux Disease (NERD) Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Nonerosive Reflux Disease (NERD) Global Clinical Trials Review, H1, 2018" provides an overview of Nonerosive Reflux Disease (NERD) clinical trials scenario. This report provides top line data relating to the clinical trials on Nonerosive Reflux Disease (NERD). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Nonerosive Reflux Disease (NERD) Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Nonerosive Reflux Disease (NERD) Global Clinical Trials Review, H2, 2016" provides an overview of Nonerosive Reflux Disease (NERD) clinical trials scenario. This report provides top line data relating to the clinical trials on Nonerosive Reflux Disease (NERD). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...